BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23255489)

  • 21. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.
    Zheng J; Lee HL; Ham YW; Song HS; Song MJ; Hong JT
    Oncotarget; 2015 Dec; 6(42):44437-51. PubMed ID: 26561202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S; Singh TR; Srivastava RK
    Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.
    Lee YS; Kim KC; Mongre RK; Kim JY; Kim YR; Choi DY; Song S; Yun J; Han SB; Yoon DY; Hong JT
    Cell Death Dis; 2019 Jul; 10(7):506. PubMed ID: 31263095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.
    Zhu Y; Lv H; Xie Y; Sheng W; Xiang J; Yang J
    Cancer Gene Ther; 2011 Sep; 18(9):627-36. PubMed ID: 21660060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on apoptosis and cell cycle arrest contribute to the antitumor responses of interleukin-27 mediated by retrovirus in human pancreatic carcinoma cells.
    Liu L; Meng J; Zhang C; Duan Y; Zhao L; Wang S; Shan B
    Oncol Rep; 2012 May; 27(5):1497-503. PubMed ID: 22293948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hinokitiol inhibits cell growth through induction of S-phase arrest and apoptosis in human colon cancer cells and suppresses tumor growth in a mouse xenograft experiment.
    Lee YS; Choi KM; Kim W; Jeon YS; Lee YM; Hong JT; Yun YP; Yoo HS
    J Nat Prod; 2013 Dec; 76(12):2195-202. PubMed ID: 24308647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
    Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
    Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.
    Sakai I; Miyake H; Terakawa T; Fujisawa M
    Cancer Sci; 2011 Apr; 102(4):769-75. PubMed ID: 21214673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
    Yasui H; Adachi M; Imai K
    Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of NF-kappa B in cancer cachexia].
    Zhou W; Jiang ZW; Jiang J; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
    Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
    Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
    Pathi S; Li X; Safe S
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase C-δ(1) regulates interleukin-1β and tumor necrosis factor-α mRNA expression.
    Chung E; Jakinovich P; Bae A; Rebecchi M
    Exp Cell Res; 2012 Oct; 318(16):1987-93. PubMed ID: 22710061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms regulating the synergism between IL-32γ and NOD for the activation of eosinophils.
    Wong CK; Dong J; Lam CW
    J Leukoc Biol; 2014 Apr; 95(4):631-42. PubMed ID: 24295830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
    Wu Y; Guo Z; Zhang D; Zhang W; Yan Q; Shi X; Zhang M; Zhao Y; Zhang Y; Jiang B; Cheng T; Bai Y; Wang J
    Int J Oncol; 2013 Nov; 43(5):1618-26. PubMed ID: 24008552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.
    Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Go EJ; Hahm KB
    Oncotarget; 2016 Feb; 7(7):7667-82. PubMed ID: 26716648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.